SFX by Ex Libris Inc.

Title:	VaginalLactobacillusisolates inhibit uropathogenicEscherichia coli
Source:	Fems Microbiology Letters [0378-1097] Atassi, Fabrice yr:2006

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Bruce, Andrew W. "Probiotics to prevent urinary tract infections: the rationale and evidence." World journal of urology 24.1 (2006): 28-32.
description	2.	Barrons, R. "Use of Lactobacillus probiotics for bacterial genitourinary infections in women: A review." Clinical therapeutics 30.3 (2008): 453-68.
description	3.	Falagas, M. "Probiotics for the treatment of women with bacterial vaginosis." Clinical microbiology and infection 13.7 (2007): 657-664.
description	4.	Michail, S. "The use of Lactobacillus GG in irritable bowel syndrome in children: a double-blind randomized control trial." The journal of pediatrics 147.2 (2005): 197-201.
description	5.	Reid, G. "The importance of guidelines in the development and application of probiotics." Current pharmaceutical design 11.1 (2005): 11-16.
description	6.	Cadieux, P. "Lactobacillus strains and vaginal ecology." JAMA 287.15 (2002): 1940-1941.
description	7.	Midulla, C. "Effectiveness of Lactobacillus-containing vaginal tablets in the treatment of symptomatic bacterial vaginosis." Clinical microbiology and infection 15.1 (2009): 67-74.
description	8.	Falagas, Matthew E E. "Probiotics for prevention of recurrent urinary tract infections in women: a review of the evidence from microbiological and clinical studies." Drugs 66.9 (2006): 1253-1261.
description	9.	Larsson, P. "Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate a 6-month, double-blind, randomized, placebo-controlled study." BMC women's health 8.1 (2008): 3-3.
description	10.	Saunders, S. "Effect of Lactobacillus challenge on Gardnerella vaginalis biofilms." Colloids and surfaces. B, Biointerfaces 55.2 (2007): 138-142.
description	11.	Reid, G. "Oral probiotics can resolve urogenital infections." FEMS immunology and medical microbiology 30.1 (2001): 49-52.
description	12.	Bittner, Alvah C C. "Prescript-Assist probiotic-prebiotic treatment for irritable bowel syndrome: a methodologically oriented, 2-week, randomized, placebo-controlled, double-blind clinical study." Clinical therapeutics 27.6 (2005): 755-61.
description	13.	Anukam, K. "Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial." Microbes and infection 8.6 (2006): 1450-4.
description	14.	Bajzer, M. "Physiology: obesity and gut flora." Nature 444.7122 (2007): 1009-10.
description	15.	Bielory, L. "Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis." The journal of allergy and clinical immunology 121.1 (2007): 116-121.
description	16.	Vaisman, N. "The efficacy of Lactobacillus reuteri ATCC 55730 in the treatment of patients with irritable bowel syndrome--a double blind, placebo-controlled, randomized study." Clinical Nutrition 24.6 (2006): 925-31.
description	17.	Kalliomaki, M. "Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial." Lancet, The 357.9262 (2001): 1076-1079.
description	18.	O'Mahony, L. "Lactobacillus and Bifidobacterium in irritable bowel syndrome: Symptom responses and relationship to cytokine profiles." Gastroenterology 128.3 (2005): 541-551.
description	19.	Kaewsrichan, J. "Selection and identification of anaerobic lactobacilli producing inhibitory compounds against vaginal pathogens." FEMS immunology and medical microbiology 48.1: 75-83.
description	20.	Vasquez, A. "Oral administration of Lactobacillus and Bifidobacterium strains of intestinal and vaginal origin to healthy human females: Re-isolation from faeces and vagina." Microbial ecology in health and disease 17.1 (2005): 15-20.